AGT haplotype in ITGA4 gene is related to antibody-mediated rejection in heart transplant patients

PLoS One. 2019 Jul 23;14(7):e0219345. doi: 10.1371/journal.pone.0219345. eCollection 2019.

Abstract

Introduction: One of the main problems involved in heart transplantation (HT) is antibody-mediated rejection (AMR). Many aspects of AMR are still unresolved, including its etiology, diagnosis and treatment. In this project, we hypothesize that variants in genes involved in B-cell biology in HT patients can yield diagnostic and prognostic information about AMR.

Methods: Genetic variants in 61 genes related to B-cell biology were analyzed by next generation sequencing in 46 HT patients, 23 with and 23 without AMR.

Results: We identified 3 single nucleotide polymorphisms in ITGA4 gene (c.1845G>A, c.2633A>G, and c.2883C>T) that conformed the haplotype AGT-ITGA4. This haplotype is associated with the development of AMR. Moreover, AMR patients with the haplotype AGT-ITGA4 present lower levels of integrin α-4 in serum samples compared to the reference GAC haplotype in control patients.

Conclusion: We can conclude that polymorphisms in genes related to the biology of B-cells could have an important role in the development of AMR. In fact, the AGT haplotype in ITGA4 gene could potentially increase the risk of AMR.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies / adverse effects*
  • Computer Simulation
  • Female
  • Genetic Predisposition to Disease
  • Graft Rejection / genetics*
  • Haplotypes / genetics*
  • Heart Transplantation*
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Integrins / genetics*
  • Male
  • Middle Aged
  • Polymorphism, Single Nucleotide / genetics

Substances

  • Antibodies
  • Integrins

Grants and funding

This work was supported by a grant from Instituto de Salud Carlos III (PI13/02174) and it is part of the research activities of the “Centro de investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV)”. Co-financed with FEDER Funds.